A banner featuring Serena Williams injecting a GLP-1 medication flew over the Cincinnati Open on August 14, putting the drug category in front of thousands of tennis fans and anyone glancing skyward. Celebrity-linked GLP-1 marketing has moved well beyond television spots and social media, and this kind of aerial advertising signals how much money is chasing new patients right now. For readers considering these medications, that means more offers, more claims, and more reasons to look closely before choosing a provider.
Aerial banner advertising is an unusual channel for prescription drug marketing, and choosing a major tennis tournament suggests the advertiser wanted broad visibility rather than a narrow audience already searching for weight loss information. The image of a well-known athlete administering an injection is meant to normalize the act of self-injecting a GLP-1 drug, which can still feel unfamiliar to new users. Sporting events draw a wide mix of ages and backgrounds, so the banner likely reached people who had never considered these medications alongside those already researching them. The stunt shows how competitive the market for new GLP-1 patients has become, with advertisers reaching for attention-grabbing tactics outside the usual television and online ads.
Effecty's telehealth program is cutting the price of entry for semaglutide by offering $100 off, which brings the first month down to $45. A lower first-month price can make it easier for someone to try a GLP-1 medication without committing to the full ongoing cost right away. Readers should still ask what the price becomes after that first month, since promotional pricing typically applies only to the initial period. Comparing the full monthly cost across providers, not just the introductory offer, is the more useful number for deciding whether a plan fits a long-term budget.
Arbor's $99 monthly plan removes the in-person doctor visit that some GLP-1 programs still require, handling the process through telehealth instead. That can save time and travel for people who live far from a prescribing doctor or who prefer not to schedule an office visit. It also means the initial evaluation happens remotely, so anyone considering this route should look closely at how the platform reviews medical history before prescribing. Lower monthly costs and remote convenience are appealing, but they are worth weighing against the level of in-person oversight a person wants for their own care.
Doctors are reporting a rise in what patients are calling zombie filler, which involves injecting fat harvested from cadavers for cosmetic purposes. They link the trend to the broader GLP-1 boom, since rapid weight loss on these medications often leaves patients with volume loss in the face and other areas, prompting some to seek fillers to restore a fuller appearance. Cadaver-derived fat is not the same as a person's own fat or standard synthetic fillers, and it raises safety questions that doctors are still working through. Anyone experiencing facial volume changes after starting a GLP-1 medication should raise the issue with a qualified provider rather than seeking out unregulated or unfamiliar injection treatments.
There is a hidden risk tied to GLP-1 medications that current and future users need to understand, according to reporting on the subject. With tens of millions of Americans now taking these drugs or considering starting them, the scale of use makes this risk relevant well beyond a small group of patients. The specifics of the risk underscore why ongoing conversations with a prescribing doctor matter throughout treatment, not just at the start. Staying informed about new findings as they emerge is a reasonable habit for anyone on a GLP-1 medication or thinking about beginning one.
The common thread across these stories is that GLP-1 medications are being marketed aggressively and packaged in increasingly convenient formats, from sky banners to $45 first months. That does not mean every offer is a good fit, and it does not mean every trend, like zombie filler, is one worth following. Before signing up for a discounted plan or trying a new procedure, take time to check what a provider requires for evaluation and follow-up, and talk with a doctor about any risks specific to your situation. How and where you start or continue GLP-1 treatment is your choice, but making it with full information will serve you better than making it quickly.
Key details
A Serena Williams GLP-1 injection ad flew over the Cincinnati Open on Aug. 14.
Effecty's telehealth GLP-1 program now offers $100 off, dropping the first month to $45.
Arbor offers a $99/month GLP-1 weight-loss plan with no in-person doctor visit required.
Doctors say the GLP-1 boom is fueling 'zombie filler,' cadaver fat injections.
There's a hidden risk of GLP-1 medications that current and future users should know.
Sources
Effecty GLP-1 program offers $100 off first month — New York Post
Kickstart GLP-1 weight loss for just $99/month — New York Post
People on Ozempic are getting 'zombie filler.' What is it? — USA TODAY